Max Healthcare Institute Limited (MAXHEALTH)
Press Release
Press Release - Q1 FY27
- Gross Revenue ₹2,982 Cr +16% YoY; Operating EBITDA ₹704 Cr +15% YoY; PAT ₹357 Cr +3% YoY
- Network Operating EBITDA margin at 24.8%, slightly down from 24.9% in Q1 FY26
- Operational bed capacity increased by 630 beds YoY to 5,379; bed occupancy steady at 75%
- Completed acquisition of 58.28% stake in Kalinga Hospital and 100% Class A shares in Yerawada Properties
- Board approved ₹425 Cr capex for brownfield tower adding 202 beds at MSSH Vaishali, commissioning expected Q4 FY30
- Board granted in-principle approval to enter medical education and set up medical colleges
- Free cash from operations ₹397 Cr; net debt increased to ₹2,384 Cr due to acquisitions and expansions
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 MAXHEALTH — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add MAXHEALTH to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Max Healthcare Institute Limited
Important.
The summary above is generated automatically from Max Healthcare Institute Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.